Hypertrophic Cardiomyopathy in Young Maine Coon Cats and the p.A31P cMyBP-C Mutation
Author Information
Author(s): Godiksen Mia TN, Granstrøm Sara, Koch Jørgen, Christiansen Michael
Primary Institution: Department of Small Animals Clinical Sciences, Faculty of Life Science, University of Copenhagen
Hypothesis
What is the clinical significance of being homozygous or heterozygous for the p.A31P cMyBP-C mutation in young Maine Coon cats?
Conclusion
Most Maine Coon cats that develop hypertrophic cardiomyopathy due to the p.A31P mutation before the age of approximately 6 years are homozygous for this mutation.
Supporting Evidence
- The prevalence of fHCM in the cohort was found to be 6.3%.
- Eighteen cats were homozygous and 89 cats were heterozygous for the mutation.
- The odds ratio for having fHCM for homozygous cats was 21.6.
- Only two cats over four years were homozygous and both were diagnosed with fHCM.
Takeaway
This study looked at Maine Coon cats to see how a specific gene mutation affects their heart health. It found that cats with two copies of the mutation are much more likely to have heart problems than those with just one copy.
Methodology
The study involved 332 Maine Coon cats examined using echocardiography and genetic testing for the p.A31P cMyBP-C mutation.
Potential Biases
The study may have selection bias as only cats from breeders who consented to participate were included.
Limitations
The study's cohort was primarily young cats, which may not fully represent the mutation's effects in older cats.
Participant Demographics
The cohort consisted of 332 Maine Coon cats, including 118 males and 214 females, with a median age of 1.5 years.
Statistical Information
P-Value
0.05
Confidence Interval
95% Cfi: 7.0; 66.2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website